Systematic Review of the Risk of Adverse Outcomes Associated with Vascular Endothelial Growth Factor Inhibitors for the Treatment of Cancer

BACKGROUND: Anti-angiogenic therapy targeted at vascular endothelial growth factor (VEGF) is now used to treat several types of cancer. We did a systematic review of randomized controlled trials (RCTs) to summarize the adverse effects of vascular endothelial growth factor inhibitors (VEGFi), focusin...

Descripción completa

Detalles Bibliográficos
Autores principales: Faruque, Labib Imran, Lin, Meng, Battistella, Marisa, Wiebe, Natasha, Reiman, Tony, Hemmelgarn, Brenda, Thomas, Chandra, Tonelli, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079504/
https://www.ncbi.nlm.nih.gov/pubmed/24988441
http://dx.doi.org/10.1371/journal.pone.0101145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079504/
https://www.ncbi.nlm.nih.gov/pubmed/24988441
http://dx.doi.org/10.1371/journal.pone.0101145

Ejemplares similares